These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 20090319

  • 1. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G, Zecca B, Monzani V, Maestroni A, Rossi P, Cazzaniga M, Manganaro D, Boiti C, Zilioli E, Borutti G, Falaschi F, Mandelli C.
    Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
    [Abstract] [Full Text] [Related]

  • 2. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A, Dzialowski I, Koch R, Gahn G.
    J Neurol Sci; 2009 Sep 15; 284(1-2):155-7. PubMed ID: 19473668
    [Abstract] [Full Text] [Related]

  • 3. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D, Lorenzano S, Agnelli G, Guidetti D, Orlandi G, Semplicini A, Toso V, Caso V, Malferrari G, Fanucchi S, Bartolomei L, Prencipe M.
    Cerebrovasc Dis; 2008 Sep 15; 25(1-2):129-35. PubMed ID: 18073466
    [Abstract] [Full Text] [Related]

  • 4. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.
    Zinkstok SM, Vermeulen M, Stam J, de Haan RJ, Roos YB.
    Cerebrovasc Dis; 2010 Sep 15; 29(1):79-81. PubMed ID: 19907167
    [Abstract] [Full Text] [Related]

  • 5. Treatment of progressive stroke with tirofiban--experience in 35 patients.
    Philipps J, Thomalla G, Glahn J, Schwarze M, Rother J.
    Cerebrovasc Dis; 2009 Sep 15; 28(5):435-8. PubMed ID: 19738371
    [Abstract] [Full Text] [Related]

  • 6. NXY-059 for acute ischemic stroke.
    Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hårdemark HG, Wasiewski WW, Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators.
    N Engl J Med; 2006 Feb 09; 354(6):588-600. PubMed ID: 16467546
    [Abstract] [Full Text] [Related]

  • 7. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes.
    Cohen M.
    J Invasive Cardiol; 2000 Dec 09; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722
    [Abstract] [Full Text] [Related]

  • 8. Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
    Ciccone A, Motto C, Abraha I, Cozzolino F, Santilli I.
    Cochrane Database Syst Rev; 2014 Mar 08; (3):CD005208. PubMed ID: 24609741
    [Abstract] [Full Text] [Related]

  • 9. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ.
    Cerebrovasc Dis; 2010 Feb 08; 29(3):263-7. PubMed ID: 20090317
    [Abstract] [Full Text] [Related]

  • 10. Ancrod for acute ischemic stroke: a new dosing regimen derived from analysis of prior ancrod stroke studies.
    Levy DE, Trammel J, Wasiewski WW, Ancrod Stroke Program (ASP) Study Team.
    J Stroke Cerebrovasc Dis; 2009 Jan 08; 18(1):23-7. PubMed ID: 19110140
    [Abstract] [Full Text] [Related]

  • 11. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 08; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 12. Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
    Siebler M, Hennerici MG, Schneider D, von Reutern GM, Seitz RJ, Röther J, Witte OW, Hamann G, Junghans U, Villringer A, Fiebach JB.
    Stroke; 2011 Sep 08; 42(9):2388-92. PubMed ID: 21852609
    [Abstract] [Full Text] [Related]

  • 13. Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
    Wang H, Li X, Liu C, Huang S, Liang C, Zhang M.
    J Stroke Cerebrovasc Dis; 2020 Aug 08; 29(8):104829. PubMed ID: 32689578
    [Abstract] [Full Text] [Related]

  • 14. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial.
    Zinkstok SM, Roos YB, ARTIS investigators.
    Lancet; 2012 Aug 25; 380(9843):731-7. PubMed ID: 22748820
    [Abstract] [Full Text] [Related]

  • 15. Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction.
    Heestermans AA, Van Werkum JW, Hamm C, Dill T, Gosselink AT, De Boer MJ, Van Houwelingen G, Hoorntje JC, Koopmans PC, Ten Berg JM, Van 't Hof AW.
    J Thromb Haemost; 2009 Oct 25; 7(10):1612-8. PubMed ID: 19682233
    [Abstract] [Full Text] [Related]

  • 16. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013 Oct 25; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 17. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI.
    Neurosurgery; 2009 Nov 25; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [Abstract] [Full Text] [Related]

  • 18. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T, Theroux P, Snapinn S, Wan Y, Montreal General Hospital, Montreal, Quebec, Canada. thao.huynh@muhc.mcgill.ca.
    Am Heart J; 2003 Oct 25; 146(4):668-73. PubMed ID: 14564321
    [Abstract] [Full Text] [Related]

  • 19. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.
    J Stroke Cerebrovasc Dis; 2008 Oct 25; 17(3):121-8. PubMed ID: 18436152
    [Abstract] [Full Text] [Related]

  • 20. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
    Boddu DB, Srinivasarao Bandaru VC, Reddy PG, Madhusudan M, Rukmini MK, Suryaprabha T, Jabeen SA, Suvarna A, Jayalakshmi SS, Meena AK, Borgohain R, Kaul S.
    Neurol India; 2010 Oct 25; 58(3):403-6. PubMed ID: 20644268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.